FdaApplication
ANDA 218150
Identifiers
- fda_app_no: ANDA218150
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2024-04-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CETRORELIX ACETATE | CETRORELIX ACETATE | EQ 0.25MG BASE/VIAL | POWDER;SUBCUTANEOUS |
1 product